PAVM Projected Dividend Yield
PAVmed Inc ( NASDAQ : PAVM )PAVmed Inc. is a multi-product, commercial-stage medical technology company. Co. operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. 21 YEAR PERFORMANCE RESULTS |
PAVM Dividend History Detail PAVM Dividend News PAVM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |